Home › Funds › Foyston, Gordon & Payne Inc › CME

Foyston, Gordon & Payne Inc position in CME

CME GROUP INC · Financials

Foyston, Gordon & Payne Inc reported holding 15,409 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$4.0M, representing 0.81% of its reported portfolio and ranking #40 among its reported holdings. Foyston, Gordon & Payne Inc has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.41K sh
Reported value held$4.04M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Foyston, Gordon & Payne Inc's CME position evolved

Foyston, Gordon & Payne Inc first disclosed a stake in CME in Q3 2023 at 18,168 shares (US$3.6M). The position peaked in Q1 2024 at 22,416 shares, worth US$4.8M. Across 13 filings, Foyston, Gordon & Payne Inc increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 15,409 shares valued at US$4.0M — an increase of 3,128 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2024 (shares rose 5% over the following quarter), a 25% increase in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.17K $3.64M New
Q4 2023 18.63K $3.92M Add
Q1 2024 22.42K $4.83M Add
Q2 2024 22.12K $4.35M Reduce
Q3 2024 15.08K $3.33M Reduce
Q4 2024 15.09K $3.51M Hold
Q1 2025 15.24K $4.04M Add
Q2 2025 15.39K $4.24M Add
Q3 2025 14.81K $4.00M Reduce
Q4 2025 14.48K $3.95M Reduce
Q1 2026 14.45K $4.27M Hold
Q2 2026 12.28K $2.71M Reduce
Q3 2026 15.41K $4.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CME and 13F data

CME (CME GROUP INC) is a Financials company. 25 other funds we track also report a position in CME — the largest reported positions include Sanders Capital, LLC (US$1.33B), RAYMOND JAMES FINANCIAL INC (US$1.08B), Fidelity International (FIL) (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CME

All CME fund holders →

FAQ

How long has Foyston, Gordon & Payne Inc held CME?

Foyston, Gordon & Payne Inc has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Foyston, Gordon & Payne Inc's current position in CME?

As of Q3 2026, Foyston, Gordon & Payne Inc holds 15.41K shares of CME (CME GROUP INC), valued at $4.04M, representing 0.81% of its reported portfolio and ranking #40.

Has Foyston, Gordon & Payne Inc been buying or selling CME?

In the latest 13F filing (Q3 2026), Foyston, Gordon & Payne Inc increased its position in CME. The position peaked in Q1 2024 at 22.42K shares.

Which other funds hold CME?

Other major institutional holders of CME include Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, Fidelity International (FIL), among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.